Adam Arkin

Research Bio

Adam Arkin is the Dean A. Richard Newton Memorial Professor of Bioengineering at the University of California, Berkeley and a Senior Faculty Scientist at Lawrence Berkeley National Laboratory. He is a leader in systems and synthetic biology and biological data science, developing experimental, computational, and AI-enabled approaches to make biology predictive, interpretable, and engineerable. His research integrates mechanistic models, large-scale biological data, and machine learning to understand and design the behavior of microbes, viruses, and complex biological networks across environmental and biomedical settings.

Arkin has played a central role in building community-scale infrastructure for predictive biology, including directing ENIGMA, which advances molecular-level understanding of microbial ecosystems, and founding and leading the DOE Systems Biology Knowledgebase (KBase), an open, global platform that integrates data, models, and workflows to accelerate biological discovery and engineering. His current research initiatives include PROTECT, which develops engineered microbiome engineering-based strategies to prevent and respond to infectious disease, and collaborative leadership in the Phage Foundry, advancing scalable, data-driven phage design for treating antibiotic resistant infection and editing natural communities.

Across these efforts, Arkin’s work bridges fundamental biological insight and real-world deployment, enabling new approaches to environmental sustainability, bioenergy, infectious disease, and bio-enabled manufacturing. His research emphasizes not only what biological systems do, but why they behave as they do—creating trustworthy, mechanistically grounded models that support translation, policy, and engineering at scale.

Research Expertise and Interest

Systems and Synthetic Biology, Environmental Microbiology of Bacteria and Viruses, Biomanufacturing, Biomedicine, Bioremediation, space, green and sustainable manufacturing, infectious disease, Biological Data Science

In the News

Solar Beats Nuclear at Many Potential Settlement Sites on Mars

The high efficiency, light weight and flexibility of the latest solar cell technology means photovoltaics could provide all the power needed for an extended mission to Mars, or even a permanent settlement there, according to a new analysis by scientists at the University of California, Berkeley.

Berkeley Lab’s Adam Arkin Wins 2013 Lawrence Award

Arkin has been named one of six recipients of the 2013 Ernest Orlando Lawrence Award by U.S. Energy Secretary Ernest Moniz. The E.O. Lawrence Award, the DOE’s highest scientific honor, is recognizing Arkin “for his work advancing biological and environmental sciences."

A Welcome Predictability

Synthetic biology is the latest and most advanced phase of genetic engineering, holding great promise for helping to solve some of the world’s most intractable problems, including the sustainable production of energy fuels and critical medical drugs, and the safe removal of toxic and radioactive waste from the environment.

Agilent helps launch new synthetic biology center

Agilent Technologies Inc. has signed up to support the newly launched Synthetic Biology Institute (SBI), which will help advance efforts to engineer cells and biological systems in ways that could transform health and medicine, energy, the environment and new materials.

Featured in the Media

Please note: The views and opinions expressed in these articles are those of the authors and do not necessarily reflect the official policy or positions of UC Berkeley.
February 3, 2025
Amber Dance

Bioengineering Professor Adam Arkin and his colleagues have "engineered the cyanobacterium Arthrospira platensis, commonly known as spirulina, to synthesize the painkiller paracetamol (acetaminophen)."

June 10, 2019
Peter Fimrite
At Berkeley's Center for Utilization of Biological Engineering in Space, or CUBES, bioengineering professor Adam Arkin is leading NASA-funded research into what plants and organisms could be genetically engineered to grow useful products in deep space. For example, Arkin says: "We have organisms that can take those sugars and make plastics out of them. ... We could literally make things that can be put into a 3-D printer, and the 3-D printer could create everything from tools to bioreactors to tables and chairs, ultimately." According to this reporter: "Some of Arkin's experiments are likely to be employed on the moon orbiter known as Gateway scheduled to launch in 2024. If all goes as planned, a whole slew of space-adapted organisms will be ready to go by 2033, the favored launch window for a manned mission to Mars." Link to slide show and video. For more on this, see the press release that was issued five years ago, when the grant was first announced.
FullStory (*requires registration)

Loading Class list ...